ALFA Finder
17:53 IST
BSE
Credit Rating
Sun Pharmaceutical Industries Credit Rating
Sun Pharma received credit ratings from CRISIL and ICRA for its proposed NCD programme and reaffirmed existing facility ratings.
Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd news stories on ALFA NewsRead the news →- Share price
- ₹1,902.30
- Market cap
- ₹4,56,426 Cr
- Revenue (annual)
- ₹58,462 Cr
- Net profit (annual)
- ₹11,479 Cr
- P/E (TTM)
- 41.6×Sector 43.8×
- Promoter holding
- 52.68%-1.80% QoQ
- FII holding
- 14.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 3Business Update 3Annual General Meeting 3Legal & Regulatory 2Earnings Call 2Debt & Borrowing 2Credit Rating 2Board Meeting Date 2Regulatory Approval 1Promoter Reclassification 1Price Movement Clarification 1Partnership 1Merger & Restructuring 1Management Change 1Financial Results 1
Time
2 announcements with these filters
20:38 IST
BSE
Credit Rating
Sun Pharmaceutical Industries Credit Rating
Sun Pharma has been assigned international issuer credit ratings of Baa1 by Moody’s and BBB+ by S&P. These investment-grade ratings reflect the company's strong financial profile.